코로나19 백신 개발사 큐어백 “임상시험서 면역반응” German biotech company, CureVac, recorded an immune reaction from a potential vaccine in a clinical trial on Monday. According to local media outlets, its CEO Franz-Werner Haas was encouraged by the interim results from…
‘코로나 입원’ 트럼프, 개발 중 항체약물과 렘데시비르, 스테로이드 등 투약 74 years old, male and overweight. President Trump has all these factors linked to more severe cases of COVID-19. To help relieve symptoms and shorten hospital stay, his physicians are…
코로나19 백신 “모든 투약자 면역 반응 생성”…글로벌 혈장치료 임상도 40배 늘어 Some promising signs of vaccines and treatments for COVID-19 are emerging. Scientists at Oxford University in the U.K. say their experimental vaccine has led to an immune response in…